Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-18

Clinical Trial Update: TAP Blocks With Ropivacaine Continuous Infusion Catheters vs Single Dose Liposomal Bupivicaine After Kidney Transplant [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing TAP blocks with ropivacaine continuous infusion catheters versus single-dose liposomal bupivacaine for postoperative analgesia …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exparel (liposomal bupivacaine)
  • Ropivacaine (Ropivacaine)

Snippet

Sponsor: University of California, Davis | Conditions: Transplant;Failure,Kidney, Pain, Postoperative | Phase 4 | Status: RECRUITING